Last reviewed · How we verify
NCT07255326: O3RETINA
Effect of Omega-3 Fatty Acids on Eye Blood Vessels in Type 1 Diabetes
NA trial testing Omega 3 Fish Oil supplements in Diabetic Retinopathy in 80 participants. Currently enrolling.
1 March 2026
Quick facts
| Lead sponsor | University of Faisalabad |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 October 2025 |
| Primary completion | 1 March 2026 |
| Estimated completion | 30 July 2026 |
| Sites | 1 location across Pakistan |
Drugs / interventions tested
- Omega 3 Fish Oil supplements — full drug profile →
Conditions studied
- Diabetic Retinopathy — all drugs for Diabetic Retinopathy →
- Type 1 Diabetes — all drugs for Type 1 Diabetes →
- Omega 3 Fatty Acids — all drugs for Omega 3 Fatty Acids →
Sponsor
University of Faisalabad
Who can join
Adults 10 to 45, any sex, with Diabetic Retinopathy or Type 1 Diabetes. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this clinical trial is to learn if omega-3 fatty acid supplements help maintain healthy blood vessels in the eyes of adults with type 1 diabetes. It will also learn about the safety of omega-3 supplements. The main questions it aims to answer are: Do omega-3 supplements improve the health of retinal blood vessels in adults with type 1 diabetes? Are there any side effects when taking omega-3 supplements? Researchers will compare participants taking omega-3 supplements to a control group (if applicable) to see if the supplements help support retinal blood vessel health. Participants will: Take a daily omega-3 supplement for the duration of the study Attend regular eye exams to monitor changes in the retina Report any side effects or health changes during the study
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07255326
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Omega 3 Fish Oil supplements
Trials testing the same drug.
- NCT06698588 — Symptom-specific Effects of Omega-3 Across Neurodevelopmental Symptoms · NA · recruiting
Other recruiting trials for Diabetic Retinopathy
Currently open trials in the same condition.
- NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
- NCT07002372 — Effect of Video Viewing on Intravitreal Injection Experience · NA · recruiting
- NCT06713720 — Remote Ischemic Conditioning for Non-Proliferative Diabetic Retinopathy · NA · recruiting
- NCT06892353 — AI-Powered DIY Screening System for Diabetic Retinopathy · NA · recruiting
- NCT06821399 — Optimization and Evaluation of the Diagnosis and Treatment System for Diabetic Retinopathy in Type 2 Diabetes Mellitus · recruiting
Other University of Faisalabad trials
Trials by the same sponsor.
- NCT07475364 — Lesion Sterilization and Tissue Repair Antibiotic Paste Versus Zinc Oxide and Eugenol Pulpectomy for Treatment of Primar · Phase 1, PHASE2 · not yet recruiting
- NCT07523503 — Unilateral Versus Bilateral Task-specific Training on Motor Impairment, Upper Extremity Function, and Hand Dexterity in · NA · recruiting
- NCT07138807 — Effect of MET vs Neck Calliet Exercises on Neck Pain and Disability in Nurses · NA · recruiting
- NCT07043959 — Comparative Effects of Isometrics Versus Range of Motion Exercises on Pain, Mobility and Functional Independence in Post · NA · completed
- NCT07094633 — Comparative Effects of Kegel Versus Clamshell Exercises on Low Back Pain in Women With Uterine Fibroids: A Randomized Cl · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07255326 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Faisalabad
- Last refreshed: 1 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07255326.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing